Welcome to YLOAN.COM
yloan.com » Health » Hyperprolactinemia: Causes, Symptoms, Prognosis, Diagnosis and Latest Treatment
Health Medical Acne Aerobics-Cardio Alternative Anti-Aging Build-Muscle Chronic-Illness Dental-Care Depression Diabetes Disability Exercise Eye-Care Fitness-Equipment Hair-Loss Medicine Meditation Nutrition Obesity Polution Quit-Smoking Sidha Supplements Yeast Infection H1N1 Swine Flu SARS herpes therapy panic surgeon hurts teeth remedies eliminate chiropractic arthritis ingredients syndrome binding anxiety surgery medication psychic dental reflux doctor relief premature emotional stress disorder implants wrinkles vision infection aging liposuction seattle stunning sweating hair treatment tinnitus

Hyperprolactinemia: Causes, Symptoms, Prognosis, Diagnosis and Latest Treatment

Hyperprolactinemia: Causes, Symptoms, Prognosis

, Diagnosis and Latest Treatment

Hyperprolactinemia is one of the most common pituitary abnormalities, which is caused by an increased secretion of prolactin (above 20ng/ml) from the pituitary gland. Although the disorder is detected in less than 1% of the general population, it has been found in up to 25% of patients with secondary amenorrhea.

The most common symptoms of hyperprolactinemia are secondary amenorrhea (cessation of menstruation) and/or galactorrhea (the secretion of breast milk in men, or in women who are not breastfeeding an infant). In men, hyperprolactinemia may also lead to decreased libido or erectile dysfunction.

Causes and Treatments


Pathologic hyperprolactinemia can have many different causes. It can be caused by prolactinomas (benign tumors of the pituitary glands), hypothyroidism or treatment with certain medications (e.g. clozapine, methyldopa, phenothiazine derivates and metoclopramide).

Among all the different causes of hyperprolactinemia, prolactinomas is the most common endogenous cause. In the U.S., hyperprolactinemia due to prolactinomas affects 3% of the female population. Since dopamine is the chemical in the brain that normally inhibits prolactin secretion, doctors may treat prolactinomas with dopamine agonists like Parlodel or Dostinex (Table 1).

For patients who developed hyperprolactinemia secondary to hypothyroidism or to the adverse effects of other medications, thyroid hormone therapy and dose reduction of the causative drugs have been recommended. If symptoms of hyperprolactinemia persist after the above measures, dopamine agonist therapy will be prescribed to control those symptoms. In patients who cannot tolerate medical treatment or in patients for whom medical treatment has failed, transsphenoidal surgical removal of prolactin-secreting pituitary adenoma is reserved as the last resort.

~

Table 1. Selected product comparison of the Hyperprolactinemia category

Dostinex

Parlodel

Bromocriptine

Efficacy

+++

++

++

Side-effect

+

++

++

Dosage

Twice per week

OD

OD

+++ Strong

++ Moderate

+ Low

Bromocriptine

Introduced by Novartis in 1978, Parlodel (bromocriptine) a dopamine agonist, reduces serum prolactin levels, inhibits prolactin secretion, and decreases the size of pituitary tumor in 70% to 100% of patients. Until the introduction of Dostinex in 1996, bromocriptine was the only agent approved by the FDA for the treatment of amennorrhea/galactorrhea secondary to hyperprolactinemias and this product was once considered the gold standard.

Today, Dostinex has replaced bromocriptine in the treatment of galactorrhea with the latter being used for other purposes. Bromocriptine is now mainly used for the treatment of Parkinson's disease, acromegaly and infertility.

Therapy with bromocriptine for hyperprolactinemia should begin with 2.5 mg daily, taken at bedtime to minimize the side effects of nausea, dizziness, and nasal congestion. The dose may be increased by 2.5 mg every week, as needed, to achieve normal serum prolactin concentrations, eliminate symptoms or both. Typical dosage of bromocriptine is 2.5 mg two or three times daily.


Dostinex

Dostinex (cabergoline), a dopamine receptor agonist, is the most commonly used product for hyperprolactinemia. Launched by Pharmacia in 1996, Dostinex is indicated only for the treatment of hyperprolactinemia.

Unlike bromocriptine, however, Dostinex possesses (1) stronger prolactin-lowering effect, (2) lower incidence of serious adverse effects and (3) a better dosing schedule.

In a large, multi-center, sequential double-blind study involving 459 women with hyperprolactinemic amenorrhea, Dostinex was shown to be more effective than bromocriptine in normalizing the prolactin level and in achieving complete clinical success (resumption of ovulatory cycles or occurrence of pregnancy).5 After two weeks of treatment, higher percentage of patients treated with Dostinex achieved a normal prolactin level than those treated with bromocriptine (83.4% vs. 58.5%, P
External Hemorrhoid Treatment - How To Cure External Hemorrhoids Rid Stretch Marks from Your Body - Your Options to Remove and Prevent Stretch Marks Healthy Eating Habits Burn Fat secret revealed - the turth about fat body, burn fat in real revealed Natural Ways To Lower Blood Pressure Effectively Healthy And Attractive Lawn The Healthy Way to Reduce Bad Cholesterol Reducing High Blood Pressure Without Medication Tips Signs and Symptoms Of Clogged Arteries A Great Flirting Body Language Tip to Help You Approach With Confidence Kymaro Body Shaper Review - Will It Give You That Sexy Look You Desire ? How To Choose The Best Mother Of The Bride Dress Color Good For A Winter Wedding Health Benefits of Fish Oil
print
www.yloan.com guest:  register | login | search IP(216.73.216.124) California / Anaheim Processed in 0.017659 second(s), 7 queries , Gzip enabled , discuz 5.5 through PHP 8.3.9 , debug code: 68 , 4361, 61,
Hyperprolactinemia: Causes, Symptoms, Prognosis, Diagnosis and Latest Treatment Anaheim